Limitorr
Payments companies reported to CMS as associated with Limitorr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Limitorr, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Limitorr
These are the largest totals companies reported as associated with Limitorr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Fernando Goldenberg | Chicago, IL | Neurology (Psychiatry & Neurology) | $91.33 |
| Ali Mansour | Chicago, IL | Neurocritical Care | $91.33 |
| Christos Lazaridis | Chicago, IL | Neurocritical Care | $91.33 |
| Uzma Samadani | Golden Valley, MN | Neurological Surgery | $76.95 |
| Huimahn Choi | Houston, TX | Neurocritical Care | $71.06 |
| Martin Herman | Chicago, IL | Neurological Surgery | $68.01 |
| John Gachiani | Tampa, FL | Neurological Surgery | $23.94 |
| Ramesh Grandhi | Salt Lake City, UT | Neurological Surgery | $19.97 |
Prescribed Limitorr?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.